Georgia Cancer Center - Northside Hospital Central Research Department — Atlanta, Georgia

Georgia Cancer Center - Northside Hospital Central Research Department is a clinical research site located in Atlanta, Georgia, United States 30341.

Crixeo Clinical Trials Trust Score: 94/100 (GOOD). This profile has not yet been claimed by the site owner.

Georgia Cancer Center - Northside Hospital Central Research Department has participated in 1 clinical trials.

Therapeutic areas: Metastatic Melanoma, Head Neck Cancer.

Sponsors: Dynavax Technologies Corporation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Atlanta

Browse all research sites in Georgia · View every site in Atlanta

Sponsor Feasibility Report

Trust Score: 94/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgia Cancer Center - Northside Hospital Central Research Department?

Georgia Cancer Center - Northside Hospital Central Research Department has a Crixeo Trust Score of 94/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgia Cancer Center - Northside Hospital Central Research Department conducted?

Georgia Cancer Center - Northside Hospital Central Research Department has 1 clinical trials on record. Their work covers Metastatic Melanoma, Head Neck Cancer.

Is Georgia Cancer Center - Northside Hospital Central Research Department accredited by Crixeo Clinical Trials?

Georgia Cancer Center - Northside Hospital Central Research Department has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgia Cancer Center - Northside Hospital Central Research Department?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.